Scrip
Human Genome Sciences' ABthrax delayed by FDA complete response
17 November 2009
Sue Sutter
Please Login to read the full article.
17 November 2009
Sue Sutter
The US FDA has issued a complete response letter for Human Genome Sciences' ABthrax (raxibacumab injection), seeking additional information about the investigational treatment for inhalational anthrax.
The company declined to characterise the nature of the issues raised by the agency except...
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
EVENTS
10 February 2010
London, UK
11 February 2010
London, UK
23 February 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
